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Growth and melanization are intimately related in melanoma cells. MSH, by prom oting 
elevated cyclic AMP levels, ca uses increases in melanization, cessation of growth , and gross 
morphologic changes in Cloud man 5-91 melaMma cells. Growth inhibition results from high 
levels of cyclic AMP while growth stimulation Occurs with lower levels. During melanization , 
oxidation products of tyrosine are generated which are toxic to the cells. Genetic studies have 
revealed that some of these processes are related through COmmon biochemical pathways . 
This article reviews work of recent yea rs on such regulatory mechanisms in melanoma. 
Melan ocytes in the skin of adult mammals divide 
infrequently. perhaps once a year, while melanoma 
cells in growing tumors divide as often as once a 
day. Transformation from the normal to the malig-
nant state thus invoh'es a fundamental change in 
the ref(Ulati on of the cell cycle. a change that is of 
central interest in cancer bi ology [11 and one that 
is not restricted t.o pigment cells. However. the 
synthesi s of melanin is a specialized function of 
the pigment cell. a nd recent evidence indicat.es 
that the processes of growth and melanization are 
intimately related in melanoma cells. In this article 
I shall review briefly what is known of these proc· 
esses. emphasizing the developments in the past 
three years. 
Most of the sludies have been carried out with 
cells from the Cloudman 5-91 mouse melanoma 
(e.g .. see [2J). a tumor that. arose spontaneously in 
a DBAI2J mouse in the 19305. These cells have 
maintained t.hei r pigment cell phenotype through 
almost four decades of growth in host mice or cell 
cu lture. They have a high level of basal pigmenta-
tion and respond vigorously to melanocyte-sti m-
ulating hormone (M5 H). Addit ional data concern-
ing normal and abnormal melanocytes can be fou nd 
in publications from three recent sym posia [3- 5] 
and in a recent review article [6}. 
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REG ULATION OF MELANIZATION 
Oxidation of Tyrosine and Dopa 
The pathway involved in the formation of mela-
nin is relatively well understood (Fig. I). Yet there 
has been some controversy as to whether a single 
enzyme, tyrosi nase. catalyzes both the conversion 
of tyrosine to dopa and the conversion of dopa to 
dopa quinone . For example, it has been postulated 
that a peroxidase is involved in the oxidation of 
tyrosine and a separate dopa oxidase in the oxida-
tion of dopa [7.8]. Evidence for the involvement of 
a single enzyme is strong, however {9- 151. Each of 
three electTOphoreticaJiy pure isoenzymes from the 
Cloud man 5-91 melanoma catalyzes both reac-
tions, demonstrating that it is at least possible for 
a s ingle enzyme to control the first two oxidative 
steps. On the other hand, there seems to be no 
doubt that peroxidase activity is present in mouse 
melanoma cells [81. but its role in the melanogene-
sis remains to be demonstra ted . (n this article we 
will assume that a single enzyme, tyrosinase, 
catalyzes the oxidation of tyrosine to dopa qui-
none. Since dopa quinone oxidizes spontaneously 
to form melanin in a test tube. it is possible that 
this conversion in vivo is a nonenzymatic one . As 
yet. no enzymes have been described which are 
involved "aft.er" the formation of dopa quinone. 
Melanin, however, is not simply a polymer of 
oxidized tyrosine, but contains many proteins of 
undefined structure and fun ction [16]. The final 
assembly of the various components takes place in 
the complex la ttice structures of the melanosomes 
(Fig. 2) [I7] a nd it is likely that. these processes 
require enzymatic catalysis. Thus. mechanisms by 
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FIG ., 1. The pathway for the formation of melanin. 
(Reprmted from 153) with the kind permission of Dr. A. 
8. Lerner and Am erI can J ournal of M edicine.) 
which the final melanin product is constructed are 
still unknown . 
Activation of Tyrosinase Following Addition of 
MSH 
Although the details of melanin synthesis are yet 
to be worked out, it seems t hat the rate-li miting 
steps in melanogenesis occur at the level of the 
oxidation of tyrosine and dopa, and the quantity of 
melanin synthesized depends on the amount of 
tyrosinase activity present in the cell. In the 
response of cells to MSH , elevated tyrosinase 
activity precedes increased melanization by sev-
eral hours [IBJ. The sequence of events is as fol-
lows : 
I. M8H binds to specifi c receptors on the outer 
cell surface [19,20 J. These receptors are probably 
glycoprotein molecules and are a specialized prod-
uct of melanocytes. Melanocytes (and melanoma 
cells) a re target cells for M8 H because they can 
receive the hormonal signal via the receptors 
[21 ,22 J. 
2. The receptor ~MSH complex ca uses an activa~ 
tion of adenylate cyclase which is also an integral 
part of the cell membrane [23). Activated adenyl-
ate cyclase catalyzes the synthesis of cyclic AMP 
from intracellular ATP. Increased cyclic AMP 
levels can be detected within 10 min following t he 
addition of M8H to Cloudman 8-91 cells in culture 
(Fig. 3) [IBJ. 
3. About B hr after cyclic AMP levels are 
elevated, tyrosinase activity increases (Fig. 4) [IB) 
and about 16 hr after that an increase in melanin 
content is detectab}e. 
How does tyrosinase actIvIty wit hin cells in~ 
crease in response to MSH ? Several possibilities 
exist: increased activity due to the synthesis of new 
enzyme, an increase in the half~ life of any existing 
enzyme, and activation of a preexisting enzyme. 
Our results support the view that M8H promotes 
activat ion of preexisting molec ules of tyros inase in 
the cells [24 J, a reaction that probably involves the 
inactivation of an inhibitor of the enzyme. There 
are a number of findings that lead to this conclu-
sion: (I) Tyrosinase activity increases in the pres-
ence of M8H even in the absence of RNA and 
protein synthesis. Therefore, the response to the 
hormone does not requ ire the synthesis of new 
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enzyme molecules. (2) M8H does not prolong the 
half-life of tyros inase in the cells. (3) Crude ex-
tracts of cells not treated with M8H contain 
factors which inhibit tyrosinase activity in ex-
trac ts of cells which have been treated with the 
hormone; M8H apparently promotes the inactiva-
t ion of these factors. (4) By purifying tyros inase 
from the cells we found that there were t.he sa me 
number of molecules of the enzyme whether or not 
the cells were pretreated with M8H . These stud ies 
led us t.o propose that the ac tion of M8H that 
brings about an increase in tyrosinase activity in 
cells of the Cloudman 8-91 melanoma involves 
the removal of an inhibitor of the enzyme. Studies 
are under way to identify the molecular inter-
mediates in the reaction. 
Cyclic AMP Is the Intracellular Mediator lor the 
MSH Response 
[ncreased melanization in response to MS H is 
mediated through cyclic AMP. The following 
pIeces of eVIdence support this hypothesis: (1) 
MSH causes the activation of adenylate cyc1ase in 
isolated membrane fractions of Cloudman 8-9 1 
tumors 123); (2) intracellular cyclic AMP levels 
rise soon after the addition of MSH to cells in 
culture [IBJ; (3) cyclic AMP or cyclic AMP ana-
~ogues will substitute for MS H in eliciting an 
Increase in tyrosinase activity and mel anization 
[25,26 J; (4) inhibitors of cyclic nucleotide phospho-
dIesterase activity such as theophylli ne [27,2Bl 
enhance the M8 H response ; and (5) other agents 
which activate adenyl ate cyclase such as prosta~ 
glandin E, (J Hendee, AB Lerner , unpublished 
data) and cholera toxin [29 J cause increases in 
tyrosinase activity. In addition. a mutant cell line 
has been described which was selected for being 
~melanotic in the presence of MSH. Upon testing 
It was fou nd that this line had a defective adenyl-
ate cyclase system 12BJ. 
~I~. 2. Elec~ron . micrograph of a. stage·II melanosome. 
ThiS IS a longttudmal section showing the lattice stru c~ 
tUre face-on (x 80,000). (Reprinted from [17] with the 
ki~d permission of Dr. G. Moellmann and Yale Joumal of 
BtOlogy and Medicine.) 
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Cell Cycle-Specific Responses to MSH 
In a study of synchronized cells we found that 
increases in intracellular cyclic AMP and tyrosin-
ase activity in response to MSH were restricted to 
the G, phase of the cell cycle 130J. Varga et al 119J 
subsequently demonstrated that the reason for the 
G2 restriction was that membrane receptors for 
M8 H were available only in this phase of the cycle. 
However, when the cells were exposed to dibutyryl 
cyclic AMP (Bt, cAMP, an active analogue of 
cyclic AMP) they responded at all points in the cell 
cycle with increased tyrosinase activity. Thus, the 
cells were continuously prepared to respond to 
cyclic AMP, but their intracellular levels of the 
nucleotide remained relatively low unless they 
were exposed to M8H in the G, phase. The cells 
themselves regulate t heir response to M8H by the 
discontinuous appearance of receptors for the hOT-
monal signal. This phenomenon will be discussed 
further in relation to growth controls. 
REG ULATION OF GROWTH 
Growth Inhib ition by Cyclic AMP 
MSH not only enhances melanization but also 
inhibits proliferation and alters morphology of 
Cloudman 8-91 cells in culture 1261. Cells become 
blocked in the G, phase of their cycle after being 
exposed to the hormone for one to three genera-
tions 128J. The inhibition of growth and the mor-
phologic changes are a result of increased levels of 
cyclic AMP. Agents such as prostaglandin E, or 
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FIG. 3. Effects of MSH on intracellular cyclic AMP 
concentration in cultured Cloud man 5 -91 melanoma 
cells . Reprinted from 118 J with the permission of the 
authors and Yale Journal of Biology and M edicine.} 
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FIG. 4. Kinetics of induction of tryrosinase activity 
foll owing exposure of Cloudman S-91 ceUs to MSH. The 
counts represent incremental ' H,O formation from L· 
tyrosine-3,5- 3 H as measured by the charcoal absorp-
tion method of Pomerantz . ( x. --- - - x. . ~- --- -~l 
MSH -t,reaLed cell s; (e----e , 0---0) control cells. 
(Reprinted from II8J with the permission of the authors 
and Yale Journal of BioLogy and Medicine .) 
cholera t.oxin which ra ise cyclic AMP levels cause 
growth inhibition: cycl ic AMP or its analogues 
inhibit growth; and agents which block cyclic 
nucleotide phosphodiesterase activity potentiate 
the inhibition. Finally. we have isolated mutants 
which are resistant to MSH and have found that 
these mutants are also resistant to dibutyryl cyclic 
AMP {28}. The growth inhibit ion of melanoma 
cells by MSH is not surprising in view of the fact 
that cyclic AMP has been shown to playa role in 
the control of proliferation of a wide variety of 
cells. For example, rapidly dividing cells such as 
those in psoriatic lesions or log-phase of growth in 
culture generally have lower levels of cyclic AMP 
than slowly dividing or stationary cells [31 ,32 J; 
some tumor viruses bring about a rapid drop in 
cyclic AMP in normal cells before the cells undergo 
a malignant transformation 133.34 J: and many 
transformed cells appear to revert to normal when 
cyclic AMP or one of its analogues is added to the 
medium of the cells in culture 135-37J or injected 
into animals harboring tumors of those cells 138. 
39 J. Pastan. Johnson, and Anderson have recently 
furnished a comprehensive review of this subject 
1401. 
Does transformation from the normal to malig-
nant state involve a change in cyclic AMP metabo-
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!ism? Since agents which stimulate adenylate cy· 
clase also inhibit growth of cells in culture , do 
similar agent.s inhibit. proliferation in vivo? Many 
peptide hormones, catecholamines, and some of 
the prostaglandins act. by stimulating adenylate 
cyclase, and it is possible (but certainly not 
proved) that these agents are involved in growth 
regulat ion. The reception of hormonal signals by 
cells has thus emerged as an important area for 
studies into the control of proliferation 141]. It is 
not known whether MSH plays a role in the 
regulation of growth of normal melanocytes : how. 
ever, we have been studying the MSH-mediated 
inhibition of grovlth of melanoma cells in order to 
better understand the biochemical basis of the 
regulation . Of interest to us is an observation that 
MSH inhibits melanoma growth in culture but not 
when the cells are grown as tumors in mice. Similar 
findings were reported for the B -16 melanoma 142]. 
The growth of B-16 tum ors was not inhibited by 
MSH even though tyrosinase activity was stimu · 
lated . Varga has proposed an explanation for this 
phenomenon based on the observation that the 
cultured cells do not exhibit MSH receptor activity 
throughout the cell cycle but rather restrict the 
availability of receptors to the G, phase . Perhaps 
MSH receptor activity is discontinuous throughout 
the cycle so t.hat intracellular cyclic AMP levels are 
low during periods of DNA synthesis and high 
during periods of melanization . This could explain 
how cells escape Pardee's proposed "G-I restric-
tion point common to normal non-proliferating 
cells " [43]. Escape from specific restrictions could 
occur through the discontinuous reception of sig-
nals (Varga, in preparation ). 
Our experiments on regulat ion of growth by 
cyclic AMP have centered on the isolation and 
analyses of mutant ce lls which are still able to grow 
when cyclic AMP levels are raised . For example, 
we found that many of the cells selected for their 
resistance to growth inhibition by MSH had also 
lost their basal pigmentation (Le., that present in 
the absence of the hormone) and , conversely, many 
cells selected for the loss of basal pigmentation 
were also resistant to growth inhibition. 'Ne con-
cluded that there is a biochemical relationship 
between resistance to MSH inhibition of growth 
and basal pigmentation because it is unlikely that 
the presence of both traits in cells selected for 
either one or the otber was coincidental. Using this 
approach we were able to delineate two additional 
biochemical relationships in the cells. (I) MSH -
induci ble tyrosinase activity does not appear to be 
related to MSH control of growth. Most cell s whi ch 
were resistant to MSH in growth could still re-
spond to MSH with increased tyrosinase activity, 
even though they had lost basal activity. (2) The 
morphologic changes seen foll owing addition of 
MSH or cyclic AMP are related to grOMh controls, 
not to pigmentation . This was concluded because 
cells resistant to MSH in growth did not exhibit 
the flattening and dendrite elongation which is 
characte ristic of MSH ·sensitive cells, even though 
Vol. 66, NO . 4 
they showed increased melanization in the pres-
ence of the hormone. 
What is the nature of the biochemical relation -
ships bet.ween the various cellular functions? It is 
probable that many if not all of the responses to 
cyclic AMP are mediated through cyclic AMP-
dependent protein kinases [441. Using the genetic 
approach , Tomkins. Coffino, Bourne, and co-work· 
ers found that many cyclic AMP-resistant ly m-
phoma cells have altered protein kinase activity 
(e.g., 145, 46]) . Simantov and Sachs recently 
reported that cyclic AMP-resist.ant neuroblastoma 
cells have protein kinases with altered sensitivity 
to temperature (47). A role for protein kinases in 
t hese systems suggests that key proteins a re phos-
phorylated or dephosphorylated in response to 
ir.creased amounts of cyclic AMP and that in 
melanoma cells these reactions are involved in the 
control of growth, melanization. and morphology. 
For example, from the above results with MSH -
resistant melanoma cells we might predict that one 
protein kinase is invol ved in the regulation of 
growth. morphology, and basal tyrosinase activity 
while a separate protein kinase controls inducible 
tyrosinase activity. Cyclic AMP-dependent protein 
kinase activity is present in crude extracts of 
Cloudman S-91 cells 1281 and we are currently 
investigating the kinases in mut.ant and wild type 
cells. In one set of experiments. Ch ristie and Kanaf 
(unpublished observations) examined the patlerns 
of protein phosphorylation in wild type cells (i.e., 
normal Cloudman S-91 cells) and a mutant cell 
line which was neither melanotic nor inhibit.ed in 
growth in the presence of MSH . Extracts of the 
cells were made and incubated for eit her 1 or 2 min 
with " P -labeled ATP in the presence or absence of 
cyclic AMP (10- > M). Aliquots of the extracts were 
then analyzed by SOS aerylamide gel electropho-
resis. 'v\'hen the gels were stained for protein bands 
with Coomassie blue. identical patterns were seen 
in mutant and wild type cells (Fig. 5a). However, 
radioautography revealed many differences be-
tween wild type and mut.ant cells (Fig. 5b). The 
arrows mark some of the more obvious differences 
in phosphorylation between wild type and mutant 
cell s: however, close examination of the x-ray film 
reveals several more. Multiple changes in protein 
phosphorylation in the mutant cells ca n best be 
explained by an alteration in a protein kinase or 
phosp hatase which alters its substrate specifici ty. 
Growth Stimulation by Cyclic AMP 
As stated above, it is well known that prolifera-
tion is blocked in a variety of cells and tissues when 
intracellular levels of cyclic AMP are raised. How-
ever, other reports show that for some cells cyclic 
AMP may have a mitogenic act-ion 1481. For 
example, it has recently been shown that DNA 
synthesis commences in normal rat livers when the 
animals are injected with Bt, cyclic AMP and 
theophylline 149]. Also, cyclic AMP levels rise 
following partial hepatectomy and remain high 
during the prereplicative period , suggesting that 
April 1976 
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FIG. 5. Analyses of proteins from wild type Cloud man 
5 -91 cells and fln amelanotic mutant. The wild Iype cells 
(PSI -wt ) and the mutant (PS I-smel -II were described in 
128 J. Ext tacts of the cells were made and incubat.ed for 
either I {Jr 2 min with lfP · labeled ATP in the presence or 
absence of cyclic AMP (10 1 M) . Aliquols of the extracts 
were then analyzed by 5DS acrylamide slab J!el electro-
phoresis. a: The ~els were stained for protein bands with 
Coomassie blue . b: X-ray fllm was applied over the gels 
to delect phosphorylated proteins. Symbols are as fol-
lows: A :0 wild type cells. B .. arnelanolie mutant. Jar 2 
.. exposu re to .1ATP for I or 2 min. - = exposure to 
cyclic AMP for the same lime period. The electrophoretic 
origin is at the top. (This figure is printed with the kind 
permission of G. Christie and P. Kanof and is part of 
on-going research for the Ph.D . thesis of Ms. Ch ristie. 
The experiments were performed in the laboratory of Dr. 
P. Greengard . l 
increased cyclic AMP levels may signal the onset of 
liver regeneration [501. Cyclic AMP may also 
trigger cell division in lymphocytes [511. 
During our isolation of melanoma cells resistant 
to the growth inhibition imposed by MSH. we 
found a clone of cells that was not only able to grow 
in the presence of MSH but actually required the 
hormone for proper growth [52J. Growth was stim-
ulated when MSH, t,heophylline. PGE " cholera 
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toxin, or Bt, cyclic AMP were added to the culture 
medium. We then found that growth of wild type 
melanoma cells was markedly stimulated by low 
levels of B, cyclic AMP (10 " M), a phenomenon 
that had previously gone unnoticed (Tab. 1) . The 
mutant appeared to differ from the wild type only 
in that it required higher levels of cyclic AMP for 
stimulation of gro\vth. We conclude that cyclic 
AMP may have a dual role in the control of growth 
in these cells, inhibiting at higher concentrations, 
but stimulating at lower concentrations. 
Toricity of M elanin Precursors 
From a variety of clinical llnd experimental 
observations. Lerner has concluded that in the 
process of melanization a pigment cel1 produces 
substances which are potentially aULOtoxic ([53J, 
see also [54 J). For example, in many patients, 
hyperpigmented skin frequently loses its pigmen-
tation. This occurs with scleroderma. morphea. 
and vitiligo. Vitiligo, which in normal persons 
frequently occurs in hyperpigmented areas such as 
around the body orifices. is also associated with 
Addison 's disease. which is associated with gener-
aliz.ed hyperpigmentation. and with melanoma . In 
addition, many phenolic and catechol reagents 
produce skin depigmentation by destruction of the 
melanocyte. Lerner has proposed that (a) normal 
melanocytes have a protective mechanism against 
the toxic substances formed during the oxidation of 
tyrosine into melanin, but. this mechanism is labile 
and easily disrupted: and (b) when the mechanism 
is disrupted. tyrosine. dopa. or other melanin 
intermediates destroy the melanocyte . Lerner pre-
dicted that a strong stimulus for synthesis of 
melanin would raise the intracellular concentra· 
tion of tyrosine. dopa. or its derivative and 
increase the likelihood of cellular self-destruction . 
Based on these predictions. \Ve have carried out 
exten i"e experimentation on the toxicity of mela-
TABLE 1. Effecl.'l ofBl ,C),ciic AMP on the grou,th rateo! 
wild ty pe Cloudman 5·91 cells 
Normal Cloud man 5 -91 melanoma cells (5 x 10 4 ) were 
inoculated into Falcon 30·ml tissue cuhure flasks in 4 ml 
P· 1O culture medium . Twenty-four hours later the me· 
dium was changed and St'2 cyclic AMP was added at the 
concentrations indicated. The length of Ii cell cycle was 
determined by measuring thE" growth rate of the cells for 8 
days . Cells were counted in a Coulte r counter. Results 
similar to these were obtained in 5 separate experiments 
[52 [. 
Molarity of B\ f cydic 
AM Pin cuJI.ure-
medium 
o 
I X lO- l 
5 x 10- ' 
1 x 10- 4 
2 )( 10 • 
4 x 10- ' 
8 -x 1O- < 
Length of cell cyc le-
(hr) 
55 
41 
39 
55 
150 
No growth 
No growth 
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nin precursors toward melanotic cells in culture 
and in animals . We originally discovered that 
tyrosine and N·acetyl tyrosine were selectively 
toxic toward melanotic cells. nonpigmented cells 
being unaffected by the presence of t hese agents 
(Fig. 6) 118J. When the growth medium is supple-
mented with tyrosine (1-6 mM) there is increased 
formation of melanin and early death of the cells. 
These studies have been extended by Hendee, 
Pawelek , and H alaban (unpublished) and the 
following points have been established . (1) of 21 
naturally occurring amino acids. only tyrosine, 
dopa. and tryptophan showed selective toxicity 
toward melanotic cells. The other amino acids had 
little or no effect on either melanotic or amelanotic 
cells. Because it has be_en reported that tryptophan 
can be incorporated into melanin by mouse mela-
noma cells [55], these results are consistent with 
Lerner's hypothesis . (2) Cells induced to form 
pigment by treatment with MSH are much more 
susceptible to the toxicity of melanin precu rsors 
than cells not exposed to the hormone (Tab . II). (3) 
Treatment of cells with phenylthiourea. a potent 
and selective inhibitor of tyrosinase activity. pro-
vides complete protection to the cells from the 
toxicity of the melanin precursors (Tab. 11 ). 
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F IG. 6. Selective toxicity of tyrosine toward melanotic 
melanoma cells. Cells were cult.ured with (0---0) or 
without (e ____e l tyrosine (5 mM) added to tbe culture 
medium . X = lower limits of detection: true values 
actually less than this. A figure similar to this was 
printed in \18]. Results are expressed as the amount of 
DNA per culture flask vs days in culture. Similar resul ts 
were obtained when either protein content or actual cell 
number was determined . 
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TABLE U. Effects of tyrosine, MSH. and phenylthiourea 
on the growth of Cloudman. S·9/ cells 
Cells were grown in F·I0 medium (lO ~ " M tyrosine) or 
in medium supplemented with additional tyros ine (10- 3 
rot ). MSH (2 x 10- 7 M) or phenylthiourea (5 X to- 4 M). 
The cell numbers were determined with a Coulter 
counter. (These data are reproduced with the permission 
of Dr. R. Ha!aban.) 
Supplement 
None 
Tyrosine 
Tyrosine + M SH 
Tyrosine + MSH + 
phenylthiourea (?TV) 
Tyrosine + PTU 
MSH 
PTU 
1m munologic Factors 
NurnberofCelJs 
( x 10'1 
DayS Day7 
65 
46 
7 
5S 
62 
50 
57 
0.3 
Melanomas are widely used as models in cancer 
immunology but it is beyond the scope of this 
article to review such work. However. some exam-
ples of current experiments in this area are in-
cluded in the references 156-60 J. 
Tum origenicity of Cells Treated with 5-Bromode-
ox.vuridine (Brdu) 
Brd U is a structural analogue of thymidine 
which can be incorporated by cells into DNA in 
place of thymidine. Muscle 161 , 62). cart ilage 163. 
64 J. and some lines of pigment cells 165, 66 J cease 
to express differentiated functions when exposed to 
Brd U, and many cells begin producing vi ruses 
when exposed to the analogue 167. 68 J. None of 
these effects is understood but the changes pro-
duced in cells are quite striking and many workers 
have studied them during the past decade. 5ilagi 
and Bruce 165) reported that mouse B-16 mela-
noma cells t reated wi th BrdU in culture go through 
striking phenotypic changes which include the loss 
of pigmentation and tumorigenicity. The loss of 
tumorigenicity appeared to be related to changes 
in antigenic proteins on the cel l surface because 
immunologically incom petent mice were the only 
compatible hosts for the BrdU-t reated cells. In a 
second series of experiments Silagi showed that 
normal mice which had been preinoculated with 
Brd U-t reated cells were no longer compatible hosts 
for untreated melanoma cells [69J. We repeated 
these experiments with Cloud man 5-91 cells and 
confirmed Silagi's findings. We inoculated more 
than 100 DBA/2J mice with Cloud man 5-91 cells 
that had been exposed to BrdU in culture and 
found that these mice became incompatible hosts 
for normal Cloudman 5-9J cells. ·'Takes" occu rred 
in less than 5% of the animals preinoculated with 
BrdU-treated cells but in more than 95 % of the 
animals which had received no prior treatment. 
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Silagi's experiments may have potential applica-
tion to melanoma therapy in humans, although as 
yet no protection has been afforded the mice when 
the treatment schedule is reversed, i.e., when 
untreated cells are inoculated first and BrdU-
t reated cells are inoculated a week later . 
The Possibility of a Vira l Etiology for Melanoma 
That some vi ruses can induce tumors in plants 
and animals has been fi rmly established . Whether 
all cancers have a viral etiology remains to be seen. 
Experiments with animal melanomas have demon-
strated the fonowing points. Structures morpho-
logically identical to oncorna (oncogenic RNA) 
viruses have been demonstrated with the electron 
microscope in Cloud man 8-91 cells by Moellmann 
et 81 [] 7 J and oncorna viruses have been isolated 
from the Green e hamster melanoma and charac-
terized by Russell [70). Normal embryoni c cells 
exposed to these viruses form mal ignant tumors in 
hamsters. Epstein et al reported earlier that a 
cell-free ult rafi ltrate of a hamster melanoma could 
prod uce melanomas in hamsters [71). 
Data have also accumulated concerning viruses 
and human mela noma. Reid and Albert [72) demo 
onstrated the presen ce of an RNA-dependent DNA 
polymerase in human ocular melanoma. This en ~ 
zyme is associated with all oncoma viruses, sug-
gesting but not proving that these vi ruses were 
present in the tumor. Balda and Birkmayer [;3) 
and Pa rso[ls et al (74\ have also presented e\'j-
dence for the presence of oncorna viruses in a var i-
ety of human melanomas. Klaus has observed 
viral-li ke particles in melanoma t issue from three 
of four patients exa mined (personal commun ica-
tion). In none of the cases is it known whet her 
these viruses played a causative role in the onset 
of the melanomas. 
DISCUSSION AND SUMMARY 
Growth and mela nizat ion are int imately related 
in mela noma cell s. MS H. by promoting elevated 
cyclic AMP levels. causes increases in melan iza~ 
tion, cessation of growth. and gross morphologic 
changes in the cells. Genetic studies have revealed 
that some of these processes a re related through 
common biochemi cal pathways. It is probable that 
protein kinases and phosphatases a re the control-
ling elements since patterns of protein phosphoryl-
ation d iffer markedly between mel anoma st rains 
responsive and nonresponsive to MSH . Tyrosine. 
dopa, and tryptophan a re selectively toxic to 
pigmented cells and the toxicity can be increased 
by treatment of the cells with MSH . The act ive 
agents a re most likel .v oxidat ion products of the 
amino acids because cells trea ted with phenylthio-
urea, a selective inhibitor of ty rosinase. a re pro-
tected from the toxicity . Tumorigenicit y of B-16 
and Cloudman S-91 cells is suppressed when the 
cells are exposed to 5-bromodeoxyuridine prior to 
implantation in host mice. Mice treated with cells 
exposed to 5-Brd U are no longer competent hosts 
for untreated melanom a cells. This phenomenon 
MELANOMA GROWTH AND PIGMENTATION 207 
seems to be related to altered antigenic ity of cells 
exposed to 5-BrdU. Experiments now point to a 
viral etiology for mouse and hamster melanomas 
but a role for oncogenic viruses in human mela ~ 
noma has not yet been established . 
Understanding the basic cellular processes in 
melanoma might eventually lead to a rational 
therapy for humans. For example, from the experi-
ments described above a var iety of protocols could 
be devised combining the use of: (a) agents which 
elevate cycl ic AMP levels. (b) melanin precursors, 
and (c) immunotherapy . We carried out several 
experiments on the treatment of mice and ham-
sters with melanomas (unpublished data). Animals 
were inoculated with melanoma cells and a few 
days later the animals were placed on a diet of 
cbow only: chow together with daily injections of 
MSH ; chow combined with high levels of tyrosine; 
or chow combined with tyrosine and M8H injec-
tions. The results showed that animals given chow 
combined with tyrosine had significantly smaller 
tumors than those fed chow only . Howev er, the 
results were compli cated by t he fact that the 
" tyrosine diet " caused the animals to eat less food 
and the starvation alone could cause a reduction in 
the s ize of the tumors. On the other hand , our most 
encouraging results have been with animals fed 
chow combined with tyrosine and MSH injections. 
These animals had the smallest tumors of the four 
groups and 5 to 10% of them had no tumors at all. 
This result cannot be explained on the basis of an 
inadequate diet and appears to be similar to our 
findin gs with cells in culture. 
It is obvious from the experiments presented 
here that controls of phenotypic express ion in 
mammalian cells are qui1e complex . The mela -
noma cell in culture provides an excellent model 
for both basic studies on controls of gene expres~ 
s ion as well as pra ctical studies for human ther-
apy. 
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ance of Marilyn Sansone. Nora Koch. Josh Morowitz. 
J ohn Hendee , Trudy M ichaud. and Elizabeth Godawska. 
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